136 results on '"Blaizot, M."'
Search Results
2. Conceptual design of the AGATA 2[formula omitted] array at LNL
3. GET: A generic electronics system for TPCs and nuclear physics instrumentation
4. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders
5. A retrospective analysis of 157 surgical procedures performed without replacement therapy in 83 unrelated factor VII‐deficient patients
6. Replacement therapy in inherited factor VII deficiency: occurrence of adverse events and relation with surgery
7. A new report of FVII-inhibitor in a patient suffering from severe congenital FVII deficiency
8. A Haut-Doubs FVII variant depending on species-derived-thromboplastin reagent (F7:p.Arg337His)
9. A new report of FVII-inhibitor in a patient suffering from severe congenital FVII deficiency: PCI06
10. Genotype and phenotype relationships in 10 Pakistani unrelated patients with inherited factor VII deficiency
11. Genotype and phenotype relationships in 10 unrelated Pakistani patients with inherited FVII deficiency: PB 2.41–2
12. Update on GGCX sequence variations causing combined deficiency of vitamin K-dependent coagulation factors (VKCFD) type 1 with a new case of compound heterozygosity: PB 1.41–1
13. Mapping of inhibitory antibodies directed to the carboxy-terminus of FVIIa in severe FVII deficiency with elongated C-terminal variant (p.A354V-p.P464Hfs†): PA 1.08–2
14. Invasive procedures and minor surgery in factor VII deficiency
15. Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII
16. Spontaneous umbilical cord haematoma and congenital factor VII deficiency
17. Recombinant activated factor VII for a patient with factor VII deficiency undergoing urgent intracerebral haematoma evacuation with underlying cavernous angioma
18. The paradoxical association between inherited factor VII deficiency and venous thrombosis
19. Successful prophylaxis against intracranial hemorrhage using weekly administration of activated recombinant factor VII in a newborn with severe factor VII deficiency
20. Paradoxical association between severe inherited FVII deficiency and coronary atherosclerosis: 17 PO 494
21. Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effect
22. Invasive procedures and minor surgery in factor VII deficiency
23. Replacement Therapy for Minor Surgery and Invasive Procedures in Factor VII Deficiency: The STER Experience
24. Comunicazione orale
25. Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER
26. Chapter 11: Petroleum systems of Syria, in L. Marlow, C. Kendall and L. Yose eds, Petroleum systems of the Tethyan region
27. A New Front-End High-Resolution Sampling Board for the New-Generation Electronics of EXOGAM2 and NEDA Detectors
28. Mapping of inhibitory antibodies directed to the carboxy-terminus of FVIIa in severe FVII deficiency with elongated C-terminal variant (p.A354V-p.P464Hfs†)
29. Immune response to treatment in a severe factor VII deficient patient: characterization of the inhibitory antibody and epitope-mapping
30. Design and test of a high-speed flash ADC mezzanine card for high-resolution and timing performance in nuclear structure experiments [Conference Paper]
31. Coagulation Factor Activity Level and Clinical Bleeding Severity in Rare Bleeding Disorders: Results Foam the European Network of Rare Bleeding Disorders (EN-RBD)
32. Factor VII deficiency: evidence that in minor surgery one-day replacement therapy is sufficient
33. Association of the homozygous nonsense mutation R402X in coagulation factor VII with asymptomatic phenotype
34. PB2235: COMPLETE DELETION OF THE CACCC BOX OF THE HBB GENE PROMOTER: A NEW MECHANISM LEADING TO A SILENT PHENOTYPE OF BETA THALASSEMIA.
35. Circulating FVIII-specific IgG, IgA and IgM memory B cells from haemophilia A patients.
36. Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies.
37. MicroTCA.0, a shelf standard adopted by the GET project for experiments in nuclear physics with the smart trigger and time stamper MUTANT.
38. A New Front-End High-Resolution Sampling Board for the New-Generation Electronics of EXOGAM2 and NEDA Detectors.
39. Digital Front-End Electronics for the Neutron Detector NEDA.
40. Design and test of a high-speed flash ADC mezzanine card for high-resolution and timing performance in nuclear structure experiments.
41. Two new double mutant alleles of the F7 gene and a literature review on alleles with two mutations in FVII deficiency.
42. A new front-end high-resolution sampling board for the new-generation electronics of EXOGAM2 and NEDA detectors.
43. A Haut-Doubs FVII variant depending on species-derivedthromboplastin reagent (F7:p.Arg337His).
44. A digital front-end electronics for the neutron detector NEDA.
45. Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies
46. Replacement therapy in inherited factor VII deficiency: occurrence of adverse events and relation with surgery
47. Digital Front-End Electronics for the Neutron Detector NEDA
48. A New Front-End High-Resolution Sampling Board for the New-Generation Electronics of EXOGAM2 and NEDA Detectors
49. A new front-end high-resolution sampling board for the new-generation electronics of EXOGAM2 and NEDA detectors
50. Design and Test of a High-speed Flash ADC Mezzanine Card for High-resolution and Timing Performance in Nuclear Structure Experiments
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.